What happened
Pfizer has a new chief financial officer. The New York-based pharmaceutical company appointed Cecile Guegan to the role, as reported by CFO Dive. She succeeds Dave Denton, who left the company in August.
CFO Dive describes the move as a promotion of an insider. Pfizer chose to fill the top finance job from within rather than run an outside search for a name from another company.
The report does not say here why Denton left, and the terms of the transition are not covered in what we have. Start dates, compensation and any changes to the wider finance leadership team are not yet announced.
Why it matters if you are hiring
The interim between a CFO leaving and a successor being named is a period every finance team feels. Decisions get deferred, direct reports wonder about their own roles, and the strongest people start taking calls from recruiters. Pfizer's choice to promote from inside shows one way to shorten that gap: have a credible internal candidate ready.
Most Canadian mid-sized employers do not have that bench. If your controller is also your only senior finance leader, a departure leaves you with no obvious successor. That affects who you hire below the top as well. A VP Finance, director of FP&A or corporate controller hired today should be someone you could picture stepping up in two or three years.
An insider promotion also creates a vacancy. When a senior finance person moves up, their old seat opens, and so on down the line. Plan for that second hire before the first announcement, not after.
One thing to do this week
Write down who would run finance if your CFO or head of finance left next month. Name one person for the top job and one for each of the two roles beneath it. Where a name is missing or the person is not ready, that is the gap to start hiring or developing against now.
Traverse places finance leaders, controllers and accounting professionals with employers across Canada and the US, and we can help you build a bench before you need it.
